-
-
-
-
-
-
-
Tarsus Pharmaceuticals Announces Oversubscribed $125.0 Million Private Placement Equity Financing
-
-
-
-
-
-
-
Tarsus Advances Eye Care Leadership Strategy with Acquisition of iRenix MedicalĀ and Late-Stage Asset IRX-101
-
-
-
-
-
-
-
Tarsus Pharmaceuticals (TARS) PT Raised to $65 at Raymond James Following Positive TP-03 Survey
1,199,245 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


